104 related articles for article (PubMed ID: 6269476)
41. Ototoxicity of ear drops: a clinical perspective.
Linder TE; Zwicky S; Brändle P
Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672
[TBL] [Abstract][Full Text] [Related]
42. Trimethoprim-polymyxin B sulfate cream versus fusidic acid cream in the treatment of pyodermas.
Jaafar RB; Pettit JH; Gibson JR; Harvey SG; Marks P; Webster A
Int J Dermatol; 1987; 26(1):60-3. PubMed ID: 3030946
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial efficacy and aqueous humor concentration of preoperative and postoperative topical trimethoprim/polymyxin B sulfate versus tobramycin.
Osher RH; Amdahl LD; Cheetham JK
J Cataract Refract Surg; 1994 Jan; 20(1):3-8. PubMed ID: 8133476
[TBL] [Abstract][Full Text] [Related]
44. Comparison of penicillin and trimethoprim-sulfamethoxazole in the treatment of ear, nose and throat infections.
Quick CA
Can Med Assoc J; 1975 Jun; 112(13 Spec No):83-6. PubMed ID: 805651
[TBL] [Abstract][Full Text] [Related]
45. [New studies relating to the preservation of aqueous solutions of vancomycin, neomycin and polymyxin B].
Cornu J; Griffiths W; Amacker PA; Schorer E
Pharm Acta Helv; 1982; 57(10-11):295-7. PubMed ID: 6292956
[No Abstract] [Full Text] [Related]
46. The weeping ear: clinical re-evaluation of treatment.
Gydé MC; Norris D; Kavalec EC
J Int Med Res; 1982; 10(5):333-40. PubMed ID: 6754505
[TBL] [Abstract][Full Text] [Related]
47. [Clinical study of sulfamethoxazole trimethoprim in ENT for suppurative otitis and rhinosinusitis].
Rostein D
Rev Laryngol Otol Rhinol (Bord); 1978; 99(1-2):157-8. PubMed ID: 353941
[No Abstract] [Full Text] [Related]
48. The effect of trimethoprim-polymyxin B sulphate ophthalmic ointment and chloramphenicol ophthalmic ointment on the bacterial flora of the eye when administered to the operated and unoperated eyes of patients undergoing cataract surgery.
Bell TA; Slack M; Harvey SG; Gibson JR
Eye (Lond); 1988; 2 ( Pt 3)():324-9. PubMed ID: 2841172
[TBL] [Abstract][Full Text] [Related]
49. [New sulfonamide-trimethoprim combination, Supristol. Results of a joint therapeutic trial (author's transl)].
Frank H; Jurisch H; Kabelitz HJ; Staudacher H; Stoll S; Summa JD; Wagner A
MMW Munch Med Wochenschr; 1977 Nov; 119(44):1441-4. PubMed ID: 412088
[TBL] [Abstract][Full Text] [Related]
50. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon.
Wright CG; Meyerhoff WL; Halama AR
Am J Otol; 1987 Nov; 8(6):495-9. PubMed ID: 2829633
[TBL] [Abstract][Full Text] [Related]
51. Trimethoprim-sulfamethoxazole v. amoxicillin in the treatment of acute otitis media.
Feldman W; Momy J; Dulberg C
CMAJ; 1988 Nov; 139(10):961-4. PubMed ID: 3052769
[TBL] [Abstract][Full Text] [Related]
52. A group III steroid solution without antibiotic components: an effective cure for external otitis.
Emgård P; Hellström S
J Laryngol Otol; 2005 May; 119(5):342-7. PubMed ID: 15949095
[TBL] [Abstract][Full Text] [Related]
53. Ototoxicity of ear drops in patients suffering from chronic otitis media.
Podoshin L; Fradis M; Ben David J
J Laryngol Otol; 1989 Jan; 103(1):46-50. PubMed ID: 2537872
[TBL] [Abstract][Full Text] [Related]
54. [Leukocytoclastic vasculitis and ear drops].
Aguirre A; Supervía A; Mínguez S; Pedro-Botet J
Med Clin (Barc); 1998 Nov; 111(18):718-9. PubMed ID: 9887441
[No Abstract] [Full Text] [Related]
55. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa.
Roland PS; Belcher BP; Bettis R; Makabale RL; Conroy PJ; Wall GM; Dupre S; Potts S; Hogg G; Weber K;
Am J Otolaryngol; 2008; 29(4):255-61. PubMed ID: 18598837
[TBL] [Abstract][Full Text] [Related]
56. [Clinically presumptive toxicity of various ear-drops].
Goffinet M
Acta Otorhinolaryngol Belg; 1977; 31(6):585-90. PubMed ID: 202140
[No Abstract] [Full Text] [Related]
57. Acute otitis externa: an update.
Schaefer P; Baugh RF
Am Fam Physician; 2012 Dec; 86(11):1055-61. PubMed ID: 23198673
[TBL] [Abstract][Full Text] [Related]
58. [Clinical effects of intravesical instillation of polymyxin B in patients with acute cystitis].
Suzuki Y; Toyota S; Katoh S; Fukushi Y; Orikasa S; Majima K
Hinyokika Kiyo; 1989 Apr; 35(4):593-6. PubMed ID: 2544087
[TBL] [Abstract][Full Text] [Related]
59. Safety of topical ear drops containing ototoxic antibiotics.
Rakover Y; Keywan K; Rosen G
J Otolaryngol; 1997 Jun; 26(3):194-6. PubMed ID: 9176804
[TBL] [Abstract][Full Text] [Related]
60. [The species composition and sensitivity of pathogenic microflora responsible for the development of otitis externa diffusa to the components of Polidexa].
Krasnozhen VN; Pokrovskaya EM; Bayazitova LT
Vestn Otorinolaringol; 2018; 83(1):65-67. PubMed ID: 29488502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
